Evidence map›Paper›PMID 27805058›Full record

ArticleScientific reports2016

Sulforaphane, a natural component of broccoli, inhibits vestibular schwannoma growth in vitro and in vivo.

Bo Gyung Kim, Takeshi Fujita, Konstantina M Stankovic, D Bradley Welling, In Seok Moon, Jae Young Choi, Jieun Yun, Jong Soon Kang, Jong Dae Lee

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Extracellular vesicles for developing targeted hearing loss therapy.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. A Unified Methodological Framework for Vestibular Schwannoma Research.Journal of visualized experiments : JoVE · 2017
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Bo Gyung KimDepartment of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea.
Takeshi FujitaDepartment of Otolaryngology, Kindai University Faculty of Medicine, Osaka, Japan.
Konstantina M StankovicEaton Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
D Bradley WellingDepartment of Otology and Laryngology, Harvard Medical School, Boston, MA, USA.
In Seok MoonDepartment of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.
Jae Young ChoiDepartment of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.
Jieun YunBioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Korea.
Jong Soon KangBioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Korea.
Jong Dae LeeDepartment of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea.
Harvard University · USKorea Research Institute of Bioscience and Biotechnology · KRSoonchunhyang University · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vestibular schwannoma (VS) is an intracranial tumor that causes significant morbidity, including hearing loss, tinnitus, dizziness, and possibly even death from brainstem compression. However, FDA-approved pharmacologic treatments for VS do not exist. Sulforaphane (SFN) is a naturally occurring isothiocyanate found in cruciferous vegetables, such as broccoli, with potent chemoprotective effects in several cell types. Our objective was to determine whether SFN is effective against VS in vitro and in vivo. Human primary VS cells, HEI-193 schwannoma cells, and SC4 Nf2

Indexed as

Xenograft Model Antitumor AssaysAnimalsApoptosisBrassicaCell Cycle CheckpointsCell Line, TumorCell ProliferationCell SurvivalFemaleHumansIsothiocyanatesMice, Inbred BALB CMice, NudeNeuroma, AcousticPhytotherapySulfoxidesIsothiocyanatessulforaphaneSulfoxides

Identifiers

PMID27805058
PMCPMC5090244
OpenAlexW2546900726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.